SAFETY AND EFFICACY OF TWO TACROLIMUS FORMULATIONS (PROGRAF® AND ADVAGRAF®) IN MALAYSIAN RENAL TRANSPLANT PATIENTS: A COMPARATIVE STUDY
Journal of University of Malaya Medical Centre
;
: 20-26, 2019.
Article
in English
| WPRIM
| ID: wpr-751173
ABSTRACT
@#A once-daily formulation of tacrolimus, Advagraf®, is increasingly being used in place of twice-daily tacrolimus, Prograf®, as a standard immunosuppressive agent for transplant patients. In this study, the clinical safety and efficacy of Advagraf® were compared with Prograf®, among multi-ethnic Malaysian renal transplanted population.
Search on Google
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Journal of University of Malaya Medical Centre
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS